Bacthera and Seres Therapeutics plan to commercialize first live biotherapeutic product

A new manufacturing facility will become operational at Lonza’s Visp site in 2024

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

Denmark-based Chr. Hansen has received regulatory approvals for human milk oligosaccharides (HMOs) for infant formula by authorities across the EU, US, Canada and... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

With consumers increasingly seeking out supplements for their health, the ingredients and details on product labels have become far more important. As the term... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

E-gamers are demanding a slew of nutritional benefits for supplements, which is seeing the space catching up with the traditional sports and athletic performance... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

As industry eyes the gut-brain axis and the potential of probiotics for leveraging a slew of health benefits, companies are spotlighting the opportunities of the... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Nestlé’s Nutrition & Health Science marked a CHF 7.7 billion (US$8 billion) sales growth in the first half of the year, the company’s latest... Read More

trans